Concepts (287)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parkinson Disease | 35 | 2025 | 739 | 5.820 |
Why?
|
| Neuropsychological Tests | 42 | 2025 | 990 | 4.270 |
Why?
|
| Cognitive Dysfunction | 13 | 2025 | 315 | 3.000 |
Why?
|
| Dementia | 12 | 2024 | 475 | 2.720 |
Why?
|
| Cultural Competency | 5 | 2023 | 53 | 2.640 |
Why?
|
| Deep Brain Stimulation | 13 | 2021 | 432 | 2.630 |
Why?
|
| Cognition Disorders | 9 | 2011 | 571 | 1.210 |
Why?
|
| Language | 8 | 2023 | 225 | 1.000 |
Why?
|
| Memory | 6 | 2023 | 356 | 0.860 |
Why?
|
| Cognition | 11 | 2025 | 811 | 0.850 |
Why?
|
| Pallidotomy | 3 | 2008 | 11 | 0.840 |
Why?
|
| Alzheimer Disease | 3 | 2021 | 866 | 0.840 |
Why?
|
| Memory Disorders | 7 | 2020 | 210 | 0.790 |
Why?
|
| Amyotrophic Lateral Sclerosis | 7 | 2018 | 192 | 0.790 |
Why?
|
| Verbal Behavior | 4 | 2010 | 52 | 0.780 |
Why?
|
| Globus Pallidus | 7 | 2014 | 69 | 0.780 |
Why?
|
| Neuropsychology | 2 | 2023 | 24 | 0.750 |
Why?
|
| Movement Disorders | 2 | 2021 | 223 | 0.730 |
Why?
|
| Aged | 46 | 2025 | 21483 | 0.710 |
Why?
|
| Subthalamic Nucleus | 4 | 2021 | 62 | 0.700 |
Why?
|
| Cues | 2 | 2019 | 101 | 0.680 |
Why?
|
| Semantics | 2 | 2019 | 28 | 0.660 |
Why?
|
| Neurosurgery | 1 | 2021 | 82 | 0.650 |
Why?
|
| Language Tests | 1 | 2019 | 26 | 0.610 |
Why?
|
| Temporal Lobe | 3 | 2010 | 118 | 0.570 |
Why?
|
| Quality of Life | 7 | 2024 | 2161 | 0.530 |
Why?
|
| Humans | 79 | 2025 | 132256 | 0.520 |
Why?
|
| Life Style | 3 | 2025 | 453 | 0.470 |
Why?
|
| Verbal Learning | 4 | 2011 | 71 | 0.460 |
Why?
|
| Pandemics | 3 | 2021 | 1186 | 0.460 |
Why?
|
| Disease Progression | 8 | 2024 | 2233 | 0.450 |
Why?
|
| Middle Aged | 38 | 2025 | 29026 | 0.440 |
Why?
|
| Functional Laterality | 9 | 2009 | 195 | 0.410 |
Why?
|
| Depression | 5 | 2021 | 1350 | 0.390 |
Why?
|
| Postoperative Complications | 6 | 2009 | 3139 | 0.380 |
Why?
|
| Male | 48 | 2025 | 65018 | 0.380 |
Why?
|
| Female | 49 | 2025 | 70791 | 0.370 |
Why?
|
| Pilot Projects | 5 | 2020 | 1444 | 0.370 |
Why?
|
| Speech Disorders | 1 | 2012 | 48 | 0.370 |
Why?
|
| Telemedicine | 4 | 2021 | 506 | 0.350 |
Why?
|
| Mental Recall | 1 | 2011 | 143 | 0.340 |
Why?
|
| Frailty | 2 | 2025 | 136 | 0.330 |
Why?
|
| Speech Articulation Tests | 1 | 2010 | 8 | 0.330 |
Why?
|
| Mental Processes | 3 | 2011 | 39 | 0.320 |
Why?
|
| Frontal Lobe | 1 | 2010 | 120 | 0.310 |
Why?
|
| Activities of Daily Living | 6 | 2022 | 429 | 0.310 |
Why?
|
| Movement | 1 | 2007 | 168 | 0.250 |
Why?
|
| Forecasting | 3 | 2023 | 373 | 0.230 |
Why?
|
| REM Sleep Behavior Disorder | 1 | 2025 | 17 | 0.230 |
Why?
|
| Aged, 80 and over | 13 | 2022 | 7140 | 0.220 |
Why?
|
| Brain | 4 | 2016 | 3194 | 0.220 |
Why?
|
| Anterior Temporal Lobectomy | 3 | 2009 | 10 | 0.220 |
Why?
|
| Parkinsonian Disorders | 2 | 2018 | 78 | 0.210 |
Why?
|
| Depressive Disorder | 1 | 2008 | 481 | 0.210 |
Why?
|
| Dopamine | 1 | 2025 | 253 | 0.210 |
Why?
|
| Frail Elderly | 1 | 2025 | 107 | 0.210 |
Why?
|
| Aging | 2 | 2025 | 1254 | 0.210 |
Why?
|
| Occupational Therapy | 1 | 2024 | 35 | 0.210 |
Why?
|
| Translations | 1 | 2023 | 18 | 0.200 |
Why?
|
| Mood Disorders | 2 | 2018 | 129 | 0.200 |
Why?
|
| Translating | 1 | 2023 | 30 | 0.200 |
Why?
|
| Republic of Korea | 1 | 2023 | 53 | 0.200 |
Why?
|
| Multimorbidity | 1 | 2023 | 23 | 0.200 |
Why?
|
| Vietnam | 1 | 2023 | 65 | 0.200 |
Why?
|
| United States | 10 | 2025 | 11675 | 0.200 |
Why?
|
| Motivation | 2 | 2018 | 330 | 0.200 |
Why?
|
| Surveys and Questionnaires | 4 | 2023 | 3995 | 0.200 |
Why?
|
| Treatment Outcome | 12 | 2017 | 13030 | 0.190 |
Why?
|
| Culturally Competent Care | 1 | 2023 | 52 | 0.190 |
Why?
|
| Epilepsy, Temporal Lobe | 1 | 2003 | 91 | 0.180 |
Why?
|
| Quarantine | 1 | 2021 | 17 | 0.180 |
Why?
|
| Implantable Neurostimulators | 1 | 2021 | 20 | 0.180 |
Why?
|
| Walking Speed | 1 | 2021 | 19 | 0.180 |
Why?
|
| Feasibility Studies | 3 | 2022 | 821 | 0.170 |
Why?
|
| Cohort Studies | 5 | 2024 | 5176 | 0.170 |
Why?
|
| HIV Seropositivity | 1 | 2001 | 128 | 0.170 |
Why?
|
| Psychomotor Performance | 3 | 2014 | 182 | 0.170 |
Why?
|
| Preoperative Care | 2 | 2021 | 368 | 0.170 |
Why?
|
| Analysis of Variance | 5 | 2018 | 1008 | 0.160 |
Why?
|
| Behavioral Symptoms | 1 | 2020 | 25 | 0.160 |
Why?
|
| Gait | 2 | 2021 | 141 | 0.160 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2020 | 132 | 0.160 |
Why?
|
| Wearable Electronic Devices | 1 | 2021 | 108 | 0.150 |
Why?
|
| Postoperative Care | 1 | 2021 | 312 | 0.150 |
Why?
|
| Frontotemporal Dementia | 2 | 2010 | 74 | 0.150 |
Why?
|
| Visual Perception | 2 | 2011 | 136 | 0.150 |
Why?
|
| Stereotypic Movement Disorder | 1 | 2018 | 13 | 0.140 |
Why?
|
| Electrodes, Implanted | 2 | 2009 | 177 | 0.140 |
Why?
|
| Emotions | 2 | 2011 | 367 | 0.140 |
Why?
|
| Restless Legs Syndrome | 1 | 2018 | 17 | 0.140 |
Why?
|
| Hippocampus | 1 | 2003 | 820 | 0.140 |
Why?
|
| Diagnosis, Differential | 1 | 2023 | 1966 | 0.130 |
Why?
|
| Geriatric Assessment | 2 | 2025 | 192 | 0.130 |
Why?
|
| Follow-Up Studies | 7 | 2014 | 5412 | 0.130 |
Why?
|
| Longitudinal Studies | 3 | 2020 | 1500 | 0.130 |
Why?
|
| Anxiety | 2 | 2015 | 1001 | 0.130 |
Why?
|
| Executive Function | 3 | 2014 | 127 | 0.120 |
Why?
|
| Genetic Testing | 1 | 2023 | 1099 | 0.120 |
Why?
|
| Patient Readmission | 1 | 2019 | 425 | 0.120 |
Why?
|
| Irritants | 1 | 1995 | 8 | 0.120 |
Why?
|
| Erythema | 1 | 1995 | 29 | 0.120 |
Why?
|
| Prospective Studies | 4 | 2024 | 6569 | 0.110 |
Why?
|
| Neurocognitive Disorders | 1 | 2015 | 78 | 0.110 |
Why?
|
| Exercise | 2 | 2022 | 860 | 0.110 |
Why?
|
| Retrospective Studies | 7 | 2021 | 17396 | 0.110 |
Why?
|
| Medication Adherence | 2 | 2015 | 326 | 0.110 |
Why?
|
| Academic Medical Centers | 2 | 2021 | 333 | 0.110 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2013 | 3853 | 0.110 |
Why?
|
| Edema | 1 | 1995 | 144 | 0.110 |
Why?
|
| Exercise Therapy | 3 | 2022 | 183 | 0.110 |
Why?
|
| Adult | 15 | 2020 | 31620 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2018 | 576 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2018 | 3018 | 0.100 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 482 | 0.100 |
Why?
|
| Disruptive, Impulse Control, and Conduct Disorders | 1 | 2014 | 34 | 0.100 |
Why?
|
| Compulsive Behavior | 1 | 2014 | 41 | 0.100 |
Why?
|
| Educational Status | 2 | 2012 | 294 | 0.100 |
Why?
|
| Aging, Premature | 1 | 2013 | 28 | 0.100 |
Why?
|
| Tetraspanins | 1 | 2013 | 31 | 0.100 |
Why?
|
| Severity of Illness Index | 4 | 2018 | 3093 | 0.100 |
Why?
|
| Leukoencephalopathies | 1 | 2013 | 61 | 0.100 |
Why?
|
| Comorbidity | 4 | 2019 | 1610 | 0.100 |
Why?
|
| Motor Activity | 2 | 2011 | 523 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2025 | 2087 | 0.100 |
Why?
|
| Data Interpretation, Statistical | 2 | 2010 | 229 | 0.090 |
Why?
|
| Antiparasitic Agents | 1 | 2012 | 31 | 0.090 |
Why?
|
| Language Development Disorders | 1 | 2013 | 179 | 0.090 |
Why?
|
| Hypotension, Orthostatic | 1 | 2011 | 22 | 0.090 |
Why?
|
| Space Perception | 2 | 2009 | 59 | 0.090 |
Why?
|
| Levodopa | 1 | 2012 | 94 | 0.090 |
Why?
|
| Language Disorders | 2 | 2009 | 26 | 0.090 |
Why?
|
| Sequence Deletion | 1 | 2013 | 526 | 0.090 |
Why?
|
| Demography | 1 | 2011 | 242 | 0.080 |
Why?
|
| Patient Admission | 1 | 2012 | 187 | 0.080 |
Why?
|
| Sneddon Syndrome | 1 | 2010 | 3 | 0.080 |
Why?
|
| Reference Values | 1 | 2011 | 703 | 0.080 |
Why?
|
| Behavior | 1 | 2010 | 74 | 0.080 |
Why?
|
| Automation | 1 | 2010 | 62 | 0.080 |
Why?
|
| Apolipoproteins E | 1 | 2010 | 201 | 0.080 |
Why?
|
| Dominance, Cerebral | 1 | 2009 | 55 | 0.080 |
Why?
|
| Age of Onset | 4 | 2013 | 626 | 0.080 |
Why?
|
| Specialization | 1 | 2010 | 80 | 0.080 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 2009 | 5 | 0.080 |
Why?
|
| Residence Characteristics | 1 | 2011 | 286 | 0.080 |
Why?
|
| Base Sequence | 1 | 2013 | 2900 | 0.070 |
Why?
|
| Cluster Analysis | 1 | 2010 | 431 | 0.070 |
Why?
|
| Spinal Puncture | 1 | 2009 | 52 | 0.070 |
Why?
|
| Chorea | 1 | 2009 | 39 | 0.070 |
Why?
|
| Disability Evaluation | 1 | 2009 | 198 | 0.070 |
Why?
|
| Stereotaxic Techniques | 2 | 1999 | 79 | 0.070 |
Why?
|
| Memory, Short-Term | 1 | 2009 | 142 | 0.070 |
Why?
|
| Survival Rate | 2 | 2010 | 2196 | 0.070 |
Why?
|
| Cyclophosphamide | 1 | 2010 | 426 | 0.070 |
Why?
|
| Huntington Disease | 1 | 2009 | 143 | 0.070 |
Why?
|
| Reaction Time | 1 | 2008 | 168 | 0.070 |
Why?
|
| Neurologic Examination | 1 | 2008 | 202 | 0.070 |
Why?
|
| Risk Assessment | 3 | 2015 | 3736 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2010 | 605 | 0.070 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2006 | 14 | 0.070 |
Why?
|
| Unemployment | 1 | 2006 | 22 | 0.060 |
Why?
|
| Patch Tests | 2 | 1997 | 7 | 0.060 |
Why?
|
| Ambulatory Care | 1 | 2010 | 412 | 0.060 |
Why?
|
| Affective Symptoms | 1 | 2006 | 63 | 0.060 |
Why?
|
| Nervous System Diseases | 1 | 2010 | 412 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 673 | 0.060 |
Why?
|
| Prevalence | 3 | 2020 | 2664 | 0.060 |
Why?
|
| Software | 1 | 2010 | 731 | 0.060 |
Why?
|
| Risk Factors | 3 | 2025 | 10946 | 0.060 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2024 | 24 | 0.050 |
Why?
|
| alpha-Synuclein | 1 | 2025 | 134 | 0.050 |
Why?
|
| Time Factors | 3 | 2008 | 6452 | 0.050 |
Why?
|
| Speech Therapy | 1 | 2024 | 15 | 0.050 |
Why?
|
| Reoperation | 1 | 2007 | 853 | 0.050 |
Why?
|
| Body Mass Index | 1 | 2010 | 1700 | 0.050 |
Why?
|
| Biomarkers | 2 | 2025 | 3403 | 0.050 |
Why?
|
| Reward | 1 | 2004 | 116 | 0.050 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2018 | 855 | 0.050 |
Why?
|
| Taiwan | 1 | 2023 | 62 | 0.050 |
Why?
|
| Sclerosis | 1 | 2003 | 38 | 0.050 |
Why?
|
| Iran | 1 | 2023 | 97 | 0.050 |
Why?
|
| Vocabulary | 1 | 2003 | 23 | 0.050 |
Why?
|
| Hospitalization | 1 | 2012 | 1902 | 0.050 |
Why?
|
| HIV Infections | 1 | 2015 | 2050 | 0.050 |
Why?
|
| Brazil | 1 | 2023 | 140 | 0.050 |
Why?
|
| Cross-Sectional Studies | 2 | 2025 | 3761 | 0.050 |
Why?
|
| Phonetics | 1 | 2003 | 45 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2018 | 796 | 0.050 |
Why?
|
| China | 1 | 2023 | 290 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 3358 | 0.050 |
Why?
|
| Postoperative Period | 1 | 2003 | 334 | 0.050 |
Why?
|
| CD4 Antigens | 1 | 2001 | 56 | 0.050 |
Why?
|
| Neurosurgeons | 1 | 2021 | 15 | 0.050 |
Why?
|
| Veterans | 2 | 2012 | 1766 | 0.040 |
Why?
|
| Neurologists | 1 | 2021 | 27 | 0.040 |
Why?
|
| Psychometrics | 1 | 2025 | 693 | 0.040 |
Why?
|
| Speech Perception | 1 | 2001 | 57 | 0.040 |
Why?
|
| Canada | 1 | 2021 | 337 | 0.040 |
Why?
|
| Health Care Surveys | 1 | 2021 | 295 | 0.040 |
Why?
|
| Meta-Analysis as Topic | 1 | 2021 | 172 | 0.040 |
Why?
|
| Thalamic Nuclei | 1 | 1999 | 18 | 0.040 |
Why?
|
| Motor Skills | 1 | 1999 | 82 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2010 | 1418 | 0.040 |
Why?
|
| Walking | 1 | 2021 | 233 | 0.040 |
Why?
|
| Hospitals, Veterans | 2 | 2012 | 348 | 0.040 |
Why?
|
| Attention | 2 | 2010 | 200 | 0.040 |
Why?
|
| Affect | 1 | 1999 | 173 | 0.040 |
Why?
|
| Social Class | 1 | 2019 | 207 | 0.040 |
Why?
|
| Caregivers | 1 | 2022 | 596 | 0.030 |
Why?
|
| Acute Disease | 1 | 2019 | 1163 | 0.030 |
Why?
|
| Time | 1 | 2016 | 99 | 0.030 |
Why?
|
| Cetrimonium Compounds | 1 | 1995 | 4 | 0.030 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1995 | 14 | 0.030 |
Why?
|
| Sodium Hydroxide | 1 | 1995 | 7 | 0.030 |
Why?
|
| Cyclohexenes | 1 | 1995 | 10 | 0.030 |
Why?
|
| Acetic Acid | 1 | 1995 | 18 | 0.030 |
Why?
|
| Patient Selection | 1 | 1999 | 731 | 0.030 |
Why?
|
| Ethanolamines | 1 | 1995 | 25 | 0.030 |
Why?
|
| Terpenes | 1 | 1995 | 30 | 0.030 |
Why?
|
| Acetates | 1 | 1995 | 80 | 0.030 |
Why?
|
| Postural Balance | 1 | 2016 | 131 | 0.030 |
Why?
|
| Self Report | 1 | 2018 | 553 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 1234 | 0.030 |
Why?
|
| Telephone | 1 | 2015 | 126 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 486 | 0.030 |
Why?
|
| Allergens | 1 | 1997 | 276 | 0.030 |
Why?
|
| Logistic Models | 2 | 2009 | 1841 | 0.030 |
Why?
|
| Neurons | 1 | 2004 | 2012 | 0.030 |
Why?
|
| Adolescent | 3 | 2006 | 20561 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2015 | 456 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2013 | 121 | 0.020 |
Why?
|
| Multicenter Studies as Topic | 1 | 2014 | 312 | 0.020 |
Why?
|
| Health Surveys | 1 | 2014 | 260 | 0.020 |
Why?
|
| Databases, Bibliographic | 1 | 2012 | 20 | 0.020 |
Why?
|
| Pharmaceutical Services | 1 | 2012 | 36 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 437 | 0.020 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2012 | 171 | 0.020 |
Why?
|
| Exons | 1 | 2013 | 806 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 247 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 2010 | 107 | 0.020 |
Why?
|
| Medication Errors | 1 | 2012 | 205 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2010 | 135 | 0.020 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2010 | 165 | 0.020 |
Why?
|
| Pedigree | 1 | 2013 | 1724 | 0.020 |
Why?
|
| Pattern Recognition, Visual | 1 | 2009 | 28 | 0.020 |
Why?
|
| Geriatrics | 1 | 2010 | 70 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2016 | 1304 | 0.020 |
Why?
|
| Pharmacy Service, Hospital | 1 | 1989 | 50 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 902 | 0.020 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2010 | 151 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 196 | 0.020 |
Why?
|
| Skin Diseases | 1 | 2010 | 136 | 0.020 |
Why?
|
| Child | 2 | 2013 | 25784 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2010 | 188 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 3771 | 0.020 |
Why?
|
| Neurology | 1 | 2010 | 118 | 0.020 |
Why?
|
| Outpatients | 1 | 2010 | 275 | 0.020 |
Why?
|
| Face | 1 | 2009 | 189 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 313 | 0.020 |
Why?
|
| Body Composition | 1 | 2010 | 550 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2013 | 1803 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 588 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 1555 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 1989 | 270 | 0.020 |
Why?
|
| Learning | 1 | 2010 | 370 | 0.020 |
Why?
|
| Psychiatry | 1 | 2010 | 272 | 0.020 |
Why?
|
| Odds Ratio | 1 | 2009 | 1255 | 0.020 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2009 | 697 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 2139 | 0.010 |
Why?
|
| Young Adult | 2 | 2010 | 9970 | 0.010 |
Why?
|
| Genotype | 1 | 2010 | 2703 | 0.010 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 674 | 0.010 |
Why?
|
| Seizures | 1 | 2008 | 895 | 0.010 |
Why?
|
| Radiography | 1 | 2004 | 819 | 0.010 |
Why?
|
| Motor Skills Disorders | 1 | 2000 | 9 | 0.010 |
Why?
|
| Microelectrodes | 1 | 1998 | 43 | 0.010 |
Why?
|
| Obesity | 1 | 2010 | 2398 | 0.010 |
Why?
|
| Hemiplegia | 1 | 1998 | 43 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2013 | 14736 | 0.010 |
Why?
|
| Algorithms | 1 | 2004 | 1725 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1998 | 158 | 0.010 |
Why?
|
| Reference Standards | 1 | 1997 | 242 | 0.010 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1989 | 13 | 0.000 |
Why?
|
| San Francisco | 1 | 1989 | 19 | 0.000 |
Why?
|
| Costs and Cost Analysis | 1 | 1989 | 166 | 0.000 |
Why?
|
| Medical Records | 1 | 1989 | 189 | 0.000 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1989 | 827 | 0.000 |
Why?
|
| Animals | 1 | 2004 | 34850 | 0.000 |
Why?
|